arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1803.04465cs.LG
收藏

用于分子性质预测的PotentialNet

PotentialNet for Molecular Property Prediction

Stanford University(斯坦福大学);Nankai University(南开大学)

Evan N. Feinberg, Debnil Sur, Zhenqin Wu, Brooke E. Husic, Huanghao Mai, Yang Li, Saisai Sun, Jianyi Yang, Bharath Ramsundar, Vijay S. Pande

摘要:

药物发现的弧线需要跨越巨大长度尺度的多参数优化问题。它们的关键参数范围从溶解度(埃)到蛋白质-配体结合(纳米)到体内毒性(米)。通过特征学习-而不是特征工程-深度神经网络有望超越传统的基于物理和基于知识的机器学习模型,用于预测与药物发现相关的分子特性。为此,我们提出了图卷积的PotentialNet家族。这些模型是专门设计的,并实现了最先进的性能,蛋白质-配体结合亲和力。我们通过在几个基于配体的任务中设定新的性能标准来进一步验证这些深度神经网络。同时,我们引入了一个新的度量,回归富集因子$EF_χ^{(R)}$,来衡量化学数据的计算模型的早期富集。最后,我们介绍了一种基于结构同源聚类的交叉验证策略,该策略可以更准确地测量模型的泛化能力,这是机器学习用于药物发现的目标与标准机器学习任务的关键区别。

英文摘要:

The arc of drug discovery entails a multiparameter optimization problem spanning vast length scales. They key parameters range from solubility (angstroms) to protein-ligand binding (nanometers) to in vivo toxicity (meters). Through feature learning---instead of feature engineering---deep neural networks promise to outperform both traditional physics-based and knowledge-based machine learning models for predicting molecular properties pertinent to drug discovery. To this end, we present the PotentialNet family of graph convolutions. These models are specifically designed for and achieve state-of-the-art performance for protein-ligand binding affinity. We further validate these deep neural networks by setting new standards of performance in several ligand-based tasks. In parallel, we introduce a new metric, the Regression Enrichment Factor $EF_χ^{(R)}$, to measure the early enrichment of computational models for chemical data. Finally, we introduce a cross-validation strategy based on structural homology clustering that can more accurately measure model generalizability, which crucially distinguishes the aims of machine learning for drug discovery from standard machine learning tasks.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑